A detailed history of Moseley Investment Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Moseley Investment Management Inc holds 1,773 shares of ABT stock, worth $203,469. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,773
Holding current value
$203,469
% of portfolio
0.08%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$100.07 - $118.13 $177,424 - $209,444
1,773 New
1,773 $202,000
Q1 2024

Apr 04, 2024

SELL
$109.52 - $120.96 $10,404 - $11,491
-95 Reduced 4.88%
1,851 $210,000
Q4 2023

Jan 25, 2024

BUY
$90.19 - $110.4 $175,509 - $214,838
1,946 New
1,946 $214,000
Q2 2023

Jul 06, 2023

BUY
$100.78 - $112.29 $204,986 - $228,397
2,034 New
2,034 $221,000
Q4 2022

Jan 24, 2023

BUY
$95.06 - $111.52 $178,332 - $209,211
1,876 New
1,876 $0
Q1 2022

Apr 21, 2022

SELL
$114.02 - $139.04 $87,225 - $106,365
-765 Reduced 26.56%
2,115 $250,000
Q4 2021

Jan 25, 2022

SELL
$115.53 - $141.46 $3,234 - $3,960
-28 Reduced 0.96%
2,880 $405,000
Q3 2021

Oct 27, 2021

SELL
$116.66 - $129.06 $49,930 - $55,237
-428 Reduced 12.83%
2,908 $341,000
Q2 2021

Aug 11, 2021

SELL
$105.79 - $124.53 $1 Million - $1.18 Million
-9,489 Reduced 73.99%
3,336 $387,000
Q1 2021

Apr 19, 2021

BUY
$108.84 - $128.23 $17,849 - $21,029
164 Added 1.3%
12,825 $1.54 Million
Q4 2020

Jan 26, 2021

SELL
$105.0 - $114.42 $7,665 - $8,352
-73 Reduced 0.57%
12,661 $1.39 Million
Q3 2020

Nov 04, 2020

BUY
$91.64 - $111.29 $122,431 - $148,683
1,336 Added 11.72%
12,734 $1.39 Million
Q2 2020

Jul 24, 2020

BUY
$76.57 - $98.0 $183,844 - $235,298
2,401 Added 26.69%
11,398 $1.04 Million
Q1 2020

Apr 20, 2020

BUY
$62.82 - $91.86 $565,191 - $826,464
8,997 New
8,997 $709,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Moseley Investment Management Inc Portfolio

Follow Moseley Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moseley Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Moseley Investment Management Inc with notifications on news.